User profiles for Stephan Schurer
Stephan SchürerUniversity of Miami Verified email at med.miami.edu Cited by 10494 |
[PDF][PDF] A proteogenomic portrait of lung squamous cell carcinoma
Lung squamous cell carcinoma (LSCC) remains a leading cause of cancer death with few
therapeutic options. We characterized the proteogenomic landscape of LSCC, providing a …
therapeutic options. We characterized the proteogenomic landscape of LSCC, providing a …
[PDF][PDF] Integrated proteogenomic characterization across major histological types of pediatric brain cancer
…, L Ding, A Iavarone, M Wiznerowicz, S Schürer… - Cell, 2020 - cell.com
We report a comprehensive proteogenomics analysis, including whole-genome sequencing,
RNA sequencing, and proteomics and phosphoproteomics profiling, of 218 tumors across 7 …
RNA sequencing, and proteomics and phosphoproteomics profiling, of 218 tumors across 7 …
Relationships between SARS-CoV-2 in wastewater and COVID-19 clinical cases and hospitalizations, with and without normalization against indicators of human …
…, M Robertson, MA Roca, K Ryon, SC Schürer… - Acs Es&T …, 2022 - ACS Publications
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in wastewater has been
used to track community infections of coronavirus disease-2019 (COVID-19), providing critical …
used to track community infections of coronavirus disease-2019 (COVID-19), providing critical …
Machine and deep learning approaches for cancer drug repurposing
Abstract Knowledge of the underpinnings of cancer initiation, progression and metastasis has
increased exponentially in recent years. Advanced “omics” coupled with machine learning …
increased exponentially in recent years. Advanced “omics” coupled with machine learning …
LINCS Data Portal 2.0: next generation access point for perturbation-response signatures
The Library of Integrated Network-Based Cellular Signatures (LINCS) is an NIH Common
Fund program with the goal of generating a large-scale and comprehensive catalogue of …
Fund program with the goal of generating a large-scale and comprehensive catalogue of …
[HTML][HTML] CLO: the cell line ontology
…, AD Diehl, UD Vempati, SC Schürer… - Journal of biomedical …, 2014 - Springer
Background Cell lines have been widely used in biomedical research. The community-based
Cell Line Ontology (CLO) is a member of the OBO Foundry library that covers the domain …
Cell Line Ontology (CLO) is a member of the OBO Foundry library that covers the domain …
[HTML][HTML] Drug repositioning in glioblastoma: a pathway perspective
Glioblastoma multiforme (GBM) is the most malignant primary adult brain tumor. The current
standard of care is surgical resection, radiation, and chemotherapy treatment, which extends …
standard of care is surgical resection, radiation, and chemotherapy treatment, which extends …
[PDF][PDF] Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
Post-translational modifications (PTMs) play key roles in regulating cell signaling and
physiology in both normal and cancer cells. Advances in mass spectrometry enable high-…
physiology in both normal and cancer cells. Advances in mass spectrometry enable high-…
Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
…, MD Cameron, D Laznik, MJ Jurczak, SC Schürer… - Nature, 2011 - nature.com
PPARγ is the functioning receptor for the thiazolidinedione (TZD) class of antidiabetes drugs
including rosiglitazone and pioglitazone 1 . These drugs are full classical agonists for this …
including rosiglitazone and pioglitazone 1 . These drugs are full classical agonists for this …
Academic cross-fertilization by public screening yields a remarkable class of protein phosphatase methylesterase-1 inhibitors
…, P Chase, PS Hodder, SC Schürer… - Proceedings of the …, 2011 - National Acad Sciences
National Institutes of Health (NIH)-sponsored screening centers provide academic researchers
with a special opportunity to pursue small-molecule probes for protein targets that are …
with a special opportunity to pursue small-molecule probes for protein targets that are …